Page 3 - Kronos Bio News Today

Kronos Bio, Inc. (NASDAQ:KRON – Get Free Report) insider Christopher Dinsmore sold 10,032 shares of Kronos Bio stock in a transaction on Tuesday, December 12th. The stock was sold at an average price of $1.30, for a total transaction of $13,041.60. Following the completion of the transaction, the insider now owns 268,335 shares in the […]

SAN MATEO, Calif. and CAMBRIDGE, Mass., Dec. 04, 2023 -- Kronos Bio, Inc. , a company dedicated to transforming the lives of those affected by cancer, today announced that Jorge DiMartino M.D.,...

SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov. 27, 2023 -- Kronos Bio, Inc. , a company dedicated to transforming the lives of those affected by cancer, today announced that Norbert Bischofberger,...

/PRNewswire/ -- The "Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2023" drug pipelines has been added to ResearchAndMarkets.coms offering....

Kronos Bio, Inc. ( NASDAQ:KRON ) insiders who purchased shares in the last 12 months were richly rewarded last week...

Company presented positive preliminary data from Phase 1 dose escalation portion of

BioPharma

By Colin Kellaher Kronos Bio is shedding about 19% of its staff as the clinical-stage biopharmaceutical moves to extend its cash runway following positive...

KRON | Complete Kronos Bio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.